LQDA Stock Up 36% after 5-Day Win Streak
Liquidia (LQDA) stock hit day 5 of a continuous streak of days with gains, with cumulative gains over this period amounting to a 36% return. The company has gained about $772 Mil in value over the last 5 days, with its current market capitalization at about $2.2 Bil. The stock remains 121.9% above its value at the end of 2024. This compares with year-to-date returns of 10% for the S&P 500.
LQDA provides inhaled dry powder treprostinil formulation for pulmonary arterial hypertension treatment. After this rally, is LQDA still a buy – or is it time to lock in gains? Deep dive with Buy or Sell LQDA.
Comparing LQDA Stock Returns With The S&P 500
The following table summarizes the return for LQDA stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | LQDA | S&P 500 |
|---|---|---|
| 1D | 3.5% | 0.0% |
| 5D (Current Streak) | 35.8% | 2.0% |
| 1M (21D) | 83.9% | 3.3% |
| 3M (63D) | 39.9% | 9.8% |
| YTD 2025 | 121.9% | 10.0% |
| 2024 | -2.2% | 23.3% |
| 2023 | 88.9% | 24.2% |
| 2022 | 30.8% | -19.4% |
What is the point? Momentum often precedes conviction. A multi-day win streak can signal growing investor confidence or spark follow-on buying. Tracking such trends can help you ride the strength, or prepare for a well-timed entry if momentum fades. However, big gains can follow sharp reversals – but how has LQDA behaved after prior drops? See LQDA Dip Buyer Analysis to learn more.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 87 S&P constituents with 3 days or more of consecutive gains and 15 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 61 | 9 |
| 4D | 6 | 1 |
| 5D | 11 | 4 |
| 6D | 7 | 1 |
| 7D or more | 2 | 0 |
| Total >=3 D | 87 | 15 |
Key Financials for Liquidia (LQDA)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $17.5 Mil | $14.0 Mil |
| Operating Income | $-73.4 Mil | $-121.3 Mil |
| Net Income | $-78.5 Mil | $-130.4 Mil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ1 | 2025 FQ2 |
|---|---|---|
| Revenues | $3.1 Mil | $8.8 Mil |
| Operating Income | $-35.4 Mil | $-37.5 Mil |
| Net Income | $-38.4 Mil | $-41.6 Mil |
While LQDA stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 – the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.